Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Windsor

$15,000.00

Proposal for a Market Assessment for thermally protected cysteines to rapidly obtain complex peptides with*multiple disulfides

EF 2019-20

Résumé
A market study will be conducted to assess the viability of commercializing a new chemical technology thatwill allow for the simple and inexpensive formation of multiple cysteine disulfide bridges within a givenpeptide-or chain of amino acids. This technology has recently had a provisional patent application 62/883332filed on August 06 to the USPTO. Disulfide bridges are formed when two cysteine amino acids use their sulfuratoms to make a new chemical bond. These bridges help organize the one-dimensional peptide chains intodefined three-dimensional shapes. When a peptide contains multiple different cysteine amino acids, multipledifferent three-dimensional shapes are possible, but generally only one is formed as the formation of thesebonds is mediated by other chaperone proteins found in the organism. Disulfide bridges are extremelyimportant in a number of small peptides including insulin and the conotoxins (which are potential analgesicsand non-addictive replacements for opioids for severe pain control). These molecules cannot be easily madeusing traditional biotechnology as standard bacterial expression systems lack the proper cellular machinery toensure that the correct disulfide bonds are formed. Consequently, many of these complex molecules are madechemically using solid-phase peptide synthesis where complex multi-step protocols are required to ensure thatthe correct disulfide bonds are formed: in some conotoxins there are 10 cysteines which makes for manypossible combinations of disulfide bridges, only one of which is active. These multistep procedures areexpensive and low-yielding. Trant and co-inventors have designed a new stimuli-triggerable method forgenerating these disulfide bridges selectively which will significantly decrease the complexity, cost, and timerequired to access these materials making many of them commercially viable for the first time. This technologywill be highly disruptive. We expect that the assessment will confirm that there is a commercial interest in thistechnology and will identify factors affecting adoption, key stakeholders and commercialization partners, andthe need for new approaches to improve the lives of millions of people in Canada and around the world.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
545138-2019
Name nom
Trant, John
Department département
Chemistry and Biochemistry
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Proposal for a Market Assessment for thermally protected cysteines to rapidly obtain complex peptides with*multiple disulfides
Keyword
NSERC
Application summary
A market study will be conducted to assess the viability of commercializing a new chemical technology thatwill allow for the simple and inexpensive formation of multiple cysteine disulfide bridges within a givenpeptide-or chain of amino acids. This technology has recently had a provisional patent application 62/883332filed on August 06 to the USPTO. Disulfide bridges are formed when two cysteine amino acids use their sulfuratoms to make a new chemical bond. These bridges help organize the one-dimensional peptide chains intodefined three-dimensional shapes. When a peptide contains multiple different cysteine amino acids, multipledifferent three-dimensional shapes are possible, but generally only one is formed as the formation of thesebonds is mediated by other chaperone proteins found in the organism. Disulfide bridges are extremelyimportant in a number of small peptides including insulin and the conotoxins (which are potential analgesicsand non-addictive replacements for opioids for severe pain control). These molecules cannot be easily madeusing traditional biotechnology as standard bacterial expression systems lack the proper cellular machinery toensure that the correct disulfide bonds are formed. Consequently, many of these complex molecules are madechemically using solid-phase peptide synthesis where complex multi-step protocols are required to ensure thatthe correct disulfide bonds are formed: in some conotoxins there are 10 cysteines which makes for manypossible combinations of disulfide bridges, only one of which is active. These multistep procedures areexpensive and low-yielding. Trant and co-inventors have designed a new stimuli-triggerable method forgenerating these disulfide bridges selectively which will significantly decrease the complexity, cost, and timerequired to access these materials making many of them commercially viable for the first time. This technologywill be highly disruptive. We expect that the assessment will confirm that there is a commercial interest in thistechnology and will identify factors affecting adoption, key stakeholders and commercialization partners, andthe need for new approaches to improve the lives of millions of people in Canada and around the world.